We are using cookies

We use cookies to help us improve this website. By continuing to use this site we assume you are giving us consent to use cookies. Find out more in our cookie policy. Close

Welcome to practical tutorials on

Tutorials were organized at Heart Failure 2019, in Athens, Greece.

Two days full of top speakers & interesting topics – join us for your patients best!

The tutorials were recorded.

Videos are now available on this site & on www.simdax.com.



What: Orion Pharma tutorials

When: Sunday-Monday, 26-27th of May

Where: Heart Failure 2019 congress, Megaron - Athens International Conference Centre, Athens, Greece

More information: https://www.escardio.org/Congresses-&-Events/Heart-Failure


The use of inotropes for correcting hemodynamic dysfunction in patients with congestive heart failure has been described over many decades.

However, negative or insufficient data has been collected on the effects of cardiac glycosides, cathecolamines, and phosphodiesthrase inhibitors on quality of life and survival.

More recently, the calcium sensitizer and potassium channel opener levosimendan has been proposed as a safer inodilator.

This series of tutorials focuses on how to use levosimendan safely and effectively in acute and advanced heart failure.


The same program with same timings was held both on Sunday and Monday.

Sunday & Monday 26-27th of May

The Acute Heart Failure settings

9:15 Guidelines and definition of AHF, therapeutic options
García-Pinilla, José M. (Malaga, Spain)

9:35 Role of hemodynamic active drugs, differential effects of drug families
von Lewinski, Dirk (Graz, Austria)

9:55 Clinical practice in AHF with different etiologies
Parissis, John (Athens, Greece)

The Advanced Heart Failure settings

11:15 Physiological effects of vaso-active drugs in AdHF?
Agostoni, Piergiuseppe (Milan, Italy)

11:35 Guidelines and definition of AdHF, therapeutic options
Yerly, Patrick (Assens, Switzerland)

11:55 When does acute decompensation start?
Pölzl, Gerhard (Innsbruck, Austria)

Differential renal effects of vasoactive drugs

13:15 Cardio-renal syndrome
Zima, Endre (Budapest, Hungary)

13:35 Differential renal effects of levosimendan on renal function in AHF and restrictive cardiomyopathy
Reinecke, Alexander (Kiel, Germany)

13:55 Clinical practice
Karason, Kristjan (Gothenburg, Sweden)

AHF or CS as a consequence of Acute Coronary Syndrome

15:15 Therapeutic options and clinical practice for ACS-induced AHF
Recio-Mayoral, Alejandro (Sevilla, Spain)

15:35 Therapeutic options and clinical practice for ACS-induced cardiogenic shock
Harjola, Veli-Pekka (Helsinki, Finland)

15:55 Clinical practice
Farmakis, Dimitrios (Athens, Greece)